Activated Ras Signaling Pathways and Reovirus Oncolysis: An Update on the Mechanism of Preferential Reovirus Replication in Cancer Cells

door Gong, Jun, Mita, Monica M.
Gepubliceerd in 2014

Bromodomain inhibitors a decade later: a promise unfulfilled?

door Mita, Monica M., Mita, Alain C.
Gepubliceerd in Br J Cancer (2020)

Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity

door Gong, Jun, Sachdev, Esha, Mita, Alain C, Mita, Monica M
Gepubliceerd in World J Methodol (2016)

Statins and pancreatic cancer

door Gong, Jun, Sachdev, Esha, Robbins, Lori A., Lin, Emily, Hendifar, Andrew E., Mita, Monica M.
Gepubliceerd in Oncol Lett (2017)

Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas

door Carew, Jennifer S., Espitia, Claudia M., Zhao, Weiguo, Mita, Monica M., Mita, Alain C., Nawrocki, Steffan T.
Gepubliceerd in Oncotarget (2017)

Pharmacokinetic study of aldoxorubicin in patients with solid tumors

door Mita, Monica M., Natale, Ronald B., Wolin, Edward M., Laabs, Brenda, Dinh, Hillary, Wieland, Scott, Levitt, Daniel J., Mita, Alain C.
Gepubliceerd in Invest New Drugs (2014)

A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours

door Schram, Alison M., Gandhi, Leena, Mita, Monica M., Damstrup, Lars, Campana, Frank, Hidalgo, Manuel, Grande, Enrique, Hyman, David M., Heist, Rebecca S.
Gepubliceerd in Br J Cancer (2018)

Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumors

door Nemunaitis, John, Mita, Alain, Stephenson, Joe, Mita, Monica M., Sarantopoulos, John, Padmanabhan-Iyer, Swami, Nanda, Nisha, Gleich, Lyon, Benichou, Annie-Claude, Craig, Adam
Gepubliceerd in 2012

A Phase II Study of Pelareorep (REOLYSIN(®)) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma

door Mahalingam, Devalingam, Goel, Sanjay, Aparo, Santiago, Patel Arora, Sukeshi, Noronha, Nicole, Tran, Hue, Chakrabarty, Romit, Selvaggi, Giovanni, Gutierrez, Andres, Coffey, Matthew, Nawrocki, Steffan T., Nuovo, Gerard, Mita, Monica M.
Gepubliceerd in Cancers (Basel) (2018)

Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation

door Carew, Jennifer S, Medina, Ernest C, Esquivel II, Juan A, Mahalingam, Devalingam, Swords, Ronan, Kelly, Kevin, Zhang, Hui, Huang, Peng, Mita, Alain C, Mita, Monica M, Giles, Francis J, Nawrocki, Steffan T
Gepubliceerd in 2010

Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies

door Mita, Monica M, Mita, Alain C, Moseley, Jennifer L, Poon, Jennifer, Small, Karen A, Jou, Ying-Ming, Kirschmeier, Paul, Zhang, Da, Zhu, Yali, Statkevich, Paul, Sankhala, Kamelesh K, Sarantopoulos, John, Cleary, James M, Chirieac, Lucian R, Rodig, Scott J, Bannerji, Rajat, Shapiro, Geoffrey I
Gepubliceerd in Br J Cancer (2017)

Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas

door Maki, Robert G., D'Adamo, David R., Keohan, Mary L., Saulle, Michael, Schuetze, Scott M., Undevia, Samir D., Livingston, Michael B., Cooney, Matthew M., Hensley, Martee L., Mita, Monica M., Takimoto, Chris H., Kraft, Andrew S., Elias, Anthony D., Brockstein, Bruce, Blachère, Nathalie E., Edgar, Mark A., Schwartz, Lawrence H., Qin, Li-Xuan, Antonescu, Cristina R., Schwartz, Gary K.
Gepubliceerd in 2009